Skip to main content
. 2023 Jun 16;66(13):8600–8613. doi: 10.1021/acs.jmedchem.3c00258

Figure 5.

Figure 5

Biodistribution of [111In]In-DO3AiBu-Bn-FGK-Fab and [111In]In-DOTA-Bn-SCN-Fab after injection to SY-tumor-bearing mice. (A) Radioactivity levels in the tumor and the kidney after 3 h injection (n = 6). Significance was determined by Student’s t-test (*p < 0.05). (B) SPECT/CT images at 2.5–3.5 h postinjection of [111In]In-DO3AiBu-Bn-FGK-Fab and [111In]In-DOTA-Bn-SCN-Fab.